Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Juvenile Ankylosing Spondylitis (Phase III)
DRKS00000071Phase 3Terminated
- Sponsor
- Asklepios Klinik Sankt Augustin
- Start
- Feb 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ankylosing spondylitis (AS) comparing Adalimumab with Placebo (2 arms). Started Feb 2009; status: terminated.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on DRKS00000071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000071.